Birgit Olsson
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research
Most-Cited Works
- → PIK3CA Mutations and PTEN Loss Correlate with Similar Prognostic Factors and Are Not Mutually Exclusive in Breast Cancer(2007)291 cited
- → Akt kinases in breast cancer and the results of adjuvant therapy(2003)164 cited
- → High‐resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1(2011)81 cited
- → Amplification of HSD17B1 and ERBB2 in primary breast cancer(2003)81 cited
- → Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer(2010)69 cited
- → Overexpression of GLUT1 in Colorectal Cancer is Independently Associated with Poor Prognosis(2011)46 cited
- → Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer(2007)33 cited
- → Knockdown of peroxisome proliferator-activated receptor-β induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells(2009)26 cited
- → Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells(2012)21 cited
- → Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients(2004)20 cited